Canon Medical Research USA Inc.
$247.3K 1 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Forestadent USA, Inc.
Forestadent USA, Inc. reported $247,052.66 across General Payments, Research, and Ownership to 351 physicians and teaching hospitals across 351 transactions.
- $247.1K Above-median payer
- All-tracks total
- 351 Above-median volume
- Transactions
- 351 Above-median reach
- Recipients
- +$20.5K
- General Payments vs PY2023
Forestadent USA, Inc. reported $247,052.66 across all CMS Open Payments tracks (General + Research + Ownership) to 351 physicians and teaching hospitals in Program Year 2024 - ranking #942 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $247,052.66, averaging $703.85 per recipient.
How Forestadent USA, Inc.'s $247.1K all-tracks total breaks down
Forestadent USA, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
19/100
Total payments
F
12/100
Transaction volume
F
13/100
Physician reach
F
13/100
Payment type diversity
F
37/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer forestadent-usa-inc Forestadent USA, Inc.
$247.1K · #942/1,925 · 0.0% industry · PY2024
- TOT $247.1K
- RANK #942
- SHARE 0.0%
- TXN 351
- RCP 351
- CAT 3
- GEN $247.1K
- ΔGEN +$20.5K
- TOP1 85.2%
- PY 2024
Volume peers
Nearest volume peer: Canon Medical Research USA Inc. ($247.3K)
Forestadent USA, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Forestadent USA, Inc.'s CMS-reported General Payments increased by $20.5K (+9.1%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: FORESTADENT USA, INC.PY2023: FORESTADENT USA, INC.PY2024: Forestadent USA, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $226,525.76
- PY2024
- $247,052.66
What the Data Shows for Forestadent USA, Inc.
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Forestadent USA, Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
Of the 3 general-payment categories charted below, "Honoraria" is the largest at $195.0K across 15 transactions, 78.9% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Forestadent USA, Inc. made 3 types of general payments. "Honoraria" is the largest category at $195.0K, 78.9% of General Payments.
How Forestadent USA, Inc. divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Honoraria | $195.0K | 15 | 78.9% |
| Food and Beverage | $27.7K | 319 | 11.2% |
| Travel and Lodging | $24.3K | 17 | 9.9% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $222,811.60 (90.2%) of $247,052.66 in this company's General Payments records across 192 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Forestadent USA, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Ronald Roncone
$210,534.14 across 42 reported transactions
- 2
Aron Dellinger
$5,462.44 across 7 reported transactions
- 3
Richard Roblee
$3,139.44 across 1 reported transactions
- 4
Lawrence Knight
$2,500.80 across 7 reported transactions
- 5
E.G. Righellis
$1,174.78 across 3 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Forestadent USA, Inc. ranks #942 of 1,925 by total payments (top 49% by spend) but is notably more concentrated than that alone would suggest -- #219 of 1,838 by HHI (top 12% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Nanovis LLC : $47.0K total payments, HHI 7351
- Atrility Medical, Inc. : $712.50 total payments, HHI 7341
- Dimension Inx Corp : $1.2K total payments, HHI 7329
- Maillefer Instruments Holding Sarl : $369.3K total payments, HHI 7308
- Gentuity, LLC : $144.4K total payments, HHI 7294
- Ortho2, LLC : $37.7K total payments, HHI 7276
- Forestadent USA, Inc. (this company) : $247.1K total payments, HHI 7271
- Celltrion Healthcare Canada Ltd. : $14.7K total payments, HHI 7263
- Mission Pharmacal Company : $82.4K total payments, HHI 7251
- Illumina, Inc. : $4.0M total payments, HHI 7249
- The Walman Optical Company : $47.1K total payments, HHI 7106
- Sebela Women's Health Inc. : $156.8K total payments, HHI 7064
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Forestadent USA, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Forestadent USA, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Forestadent USA, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Sentynl Therapeutics, Inc.
$245.9K 44 recipients
Compare payment profiles
Nico Corporation
$245.7K 49 recipients
Compare payment profiles
Purdue Pharmaceuticals L.P.
$248.5K 50 recipients
Compare payment profiles
Total Joint Orthopedics, Inc.
$245.5K 360 recipients
Compare payment profiles
Vivus LLC
$245.5K 3,639 recipients
Compare payment profiles
Put this to use
Forestadent USA, Inc. ranks #942 of 1,925 by all-tracks total payments, led by "Honoraria".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Honoraria" spend across every manufacturer, not just Forestadent USA, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.